Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 21, 2013; 19(23): 3634-3641
Published online Jun 21, 2013. doi: 10.3748/wjg.v19.i23.3634
Table 1 Comparison of imaging findings
Imaging featuresData of assessable patientsKappaP
f-AIP (n = 19)f-PC (n = 30)
Sausage-shaped enlargement0.58 (11/19)0.03 (1/30)0.58< 0.001
Delayed homogeneous enhancement1.00 (19/19)0.1 (3/30)0.88< 0.001
Hypoattenuating capsule-like rim0.63 (12/19)0.03 (1/30)0.64< 0.001
Distal pancreatic atrophy0.30 (3/10)0.95 (20/22)-0.55< 0.001
MPD
Normal0 (0/19)0 (0/30)NS
Irregular narrowing0.58 (11/19)0.06 (2/30)0.05NS
Complete obstruction0.42 (8/19)0.93 (28/30)-0.06NS
CBD
Normal0.53 (10/19)0.47 (14/30)-0.360.027
Stenosis10.29 (4/14)0 (0/14)0.30.022
Complete obstruction0 (3/19)0.53 (16/30)-0.38< 0.01
MPD upstream dilation ≤ 5 mm1.00 (10/10)0.14 (5/22)0.66< 0.001
Affected location of pancreas
Head0.26 (5/19)0.53 (16/30)-0.08NS
Body0.26 (5/19)0.2 (6/30)-0.27NS
Tail0.47 (9/19)0.27 (8/30)0.11NS
Other findings
Vascular invasion0 (0/19)0.13 (4/30)-0.17NS
Pancreatic lymph node0.16 (3/19)0.87 (26/30)-0.65< 0.001
Calcification0 (1/19)0 (0/30)NS
Table 2 Mean computed tomography attenuation values
GroupnConditionUnenhanced scan (HU)Arterial phase (HU)Pancreatic phase (HU)Hepatic phase (HU)
f-AIP19Lesions36 ± 460 ± 785 ± 695 ± 7
Uninvolved pancreas42 ± 583 ± 10105 ± 1495 ± 7
Liver57 ± 468 ± 8119 ± 15100 ± 10
Spleen48 ± 3111 ± 15129 ± 1596 ± 9
PC30Lesion34 ± 548 ± 1063 ± 1563 ± 13
Uninvolved pancreas39 ± 676 ± 14103 ± 1587 ± 12
Liver58 ± 669 ± 9108 ± 17102 ± 10
Spleen46 ± 4102 ± 19141 ± 18101 ± 7
Normal30Pancreas44 ± 787 ± 12105 ± 2093 ± 10
Liver57 ± 765 ± 8110 ± 1899 ± 13
Spleen47 ± 4107 ± 17133 ± 2399 ± 11